FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US, Authority Hl7

17,481 resources

Type: Text:

By Version

 

Start Prev Rows 12600 - 12800 Next

PackageVersionIdentityName/TitleStatusFMMWGDate
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.526.3.471Bilateral Oophorectomyactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.526.3.485Chemotherapyactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.526.3.509Tobacco Use Cessation Counselingactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1498Medications for Above Normal BMIactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1499Medications for Below Normal BMIactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1519Follow Up for Above Normal BMIactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1523Follow Up for Above Normal BMIactive2017-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1524Follow Up for BMI Outside Normal Parametersactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1525Follow Up for Above Normal BMIactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1526Follow Up for Above Normal BMIactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1527Referrals Where Weight Assessment May Occuractive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1528Follow Up for Below Normal BMIactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1549Follow Up for Below Normal BMIactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1550Follow Up for Below Normal BMIactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1551Follow Up for Below Normal BMIactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1578Palliative Careactive2021-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1579Palliative or Hospice Careactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1608Encounter to Document Medicationsactive2025-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1609Encounter to Document Medicationsactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1610Referrals Where Weight Assessment May Occuractive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1751Encounter to Evaluate BMIactive2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1834Encounter to Document Medicationsactive2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.1917Encounter to Document Medicationsactive2021-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.695Encounter to Evaluate BMIactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.885Encounter to Evaluate BMIactive2018-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1.886Encounter to Evaluate BMIactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1475Referral to Primary Care or Alternate Provideractive2021-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1476Pharmacologic Therapy for Hypertensionactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1482Laboratory Tests for Hypertensionactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1497Encounter to Screen for Blood Pressureactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1508Lifestyle Recommendationactive2025-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1509Weight Reduction Recommendedactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1510Weight Reduction Recommendedactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1511Dietary Recommendationsactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1512Dietary Recommendationsactive2025-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1514Dietary Recommendationsactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1515Dietary Recommendationsactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1516Exercise Classactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1518Recommendation to Increase Physical Activityactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1537Follow Up Within 4 Weeksactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1538Encounter to Screen for Depressionactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1914Encounter to Screen for Depressionactive2020-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1915Encounter to Screen for Depressionactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1916Encounter to Screen for Depressionactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1918Encounter to Screen for Blood Pressureactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.192Encounter to Screen for Blood Pressureactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.1920Encounter to Screen for Blood Pressureactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.2387Overweight or Obeseactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.2388Underweightactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.2395Finding of Hypertensionactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.2462Laboratory Tests for Hypertensionactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.2466Dental Tooth Extractionactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.259Diagnosis of Hypertensionactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.261Diagnosis of Hypertensionactive2021-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.263Diagnosis of Hypertensionactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.467Follow Up for Adolescent Depressionactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.468Follow Up for Adult Depressionactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.469Adolescent Depression Medicationsactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.470Adult Depression Medicationsactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.537Referral for Adolescent Depressionactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.538Referral for Adult Depressionactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.791Patient Declinedactive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.805Weight Reduction Recommendedactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.810Recommendation to Increase Physical Activityactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.600.823Referral or Counseling for Alcohol Consumptionactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.6366.117Absence of Cervixactive2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.1743General or Neuraxial Anesthesiaactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.1940Immunocompromised Conditionsactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.2262CABG Surgeriesactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.2328Immunocompromised Conditions I10active2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.2343Immunocompromised Conditionsactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.3011Acute Myocardial Infarctionactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.3024Acute Myocardial Infarctionactive2016-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.307Encounter Inpatientactive2020-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.335Bone Marrow Transplantactive2021-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.336Bone Marrow Transplantactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.404Bone Marrow Transplantactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.623Acute Myocardial Infarctionactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.694CABG Surgeriesactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.737PCIactive2018-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.666.5.747Endotracheal Intubationactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.128Bipolar Disorderactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.246Personality Disorder Emotionally Labileactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.247Personality Disorder Emotionally Labileactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.248Personality Disorder Emotionally Labileactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.249Personality Disorder Emotionally Labileactive2023-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.254Dysthymiaactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.256Dysthymiaactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.257Dysthymiaactive2023-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.262Deceasedactive2014-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.263PHQ 9 and PHQ 9M Toolsactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.269Hepatitis Bactive2017-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.271Hepatitis Bactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.272Hepatitis Bactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.43Bipolar Disorderactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.44Bipolar Disorderactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.1.45Bipolar Disorderactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.11.721Deceasedactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.67.1.101.11.723PHQ-9 Toolactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.6929.2.1000Estimated Glomerular Filtration Rateactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.6929.2.1002Urine Albumin Creatinine Ratioactive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.6929.3.1000Estimated Glomerular Filtration Rateactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.6929.3.1007Urine Albumin Creatinine Ratioactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1000Strabismic Amblyopiaactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1001Strabismic Amblyopiaactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1002Refractive Amblyopiaactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1003Refractive Amblyopiaactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1004Routine Ophthalmological Examinationactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1005Pediatric Best Corrected Visual Acuity Examactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1006LogMAR Visual Acuity Examactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1007Aphakiaactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1008Aphakiaactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1009Infantile and Juvenile Cataractactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1010Infantile and Juvenile Cataractactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1011Congenital Corneal or Anterior Segment Conditionsactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1012Congenital Corneal or Anterior Segment Conditionsactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1013Eyelid or Orbital Conditionsactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1014Eyelid or Orbital Conditionsactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1015Coloboma of Optic Discactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1016Coloboma of Optic Discactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1017Hemorrhage of Optic Nerve Sheathactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1018Hemorrhage of Optic Nerve Sheathactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1019Optic Nerve Hypoplasiaactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1020Optic Nerve Hypoplasiaactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1021Disorder of Visual Cortex Due to Underlying Conditionactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1022Disorder of Visual Cortex Due to Underlying Conditionactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1023Cortical Blindnessactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1024Cortical Blindnessactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1025Congenital Condition of Retinaactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.2.1026Congenital Condition of Retinaactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1000Strabismic Amblyopiaactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1001Refractive Amblyopiaactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1002Routine Ophthalmological Examinationactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1003Pediatric Best Corrected Visual Acuity Examactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1004LogMAR Visual Acuity Examactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1005Aphakiaactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1006Infantile and Juvenile Cataractactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1007Congenital Corneal or Anterior Segment Conditionsactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1008Eyelid or Orbital Conditionsactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1009Coloboma of Optic Discactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1010Hemorrhage of Optic Nerve Sheathactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1011Optic Nerve Hypoplasiaactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1012Disorder of Visual Cortex Due to Underlying Conditionactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1013Cortical Blindnessactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.8420.3.1014Congenital Condition of Retinaactive2019-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.3221.6.2Allergy and Intolerance Typeactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.3221.7.2Problem Type (SNOMEDCT)active2025-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.3221.8.7SPL Drug Route of Administration Terminologyactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.88.12.80.62Vital Sign Result Typeactive2024-03
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3180NHSNInsertionSiteCodeactive2020-06
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3181NHSNRoleOfPerformerCodeactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3182NHSNReasonForInsertionCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3183NHSNSkinPreparationCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3184NHSNSterileBarrierCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3185NHSNCatheterTypeCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3194NHSNSignificantPathogenCodeactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3195NHSNCriterionOfDiagnosisCodeactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3196NHSNInfectionConditionCodeactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3234NHSNPopulationCategoryCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3247NHSNTimingCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3248NHSNEligibilityCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3249NHSNSpecimenTypeCodeactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3283NHSNOrganismASTCodeactive2020-06
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3360NHSNAntimicrobialAgentAURPCodeactive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3361NHSNRouteOfAdministrationAURPCodeactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.3595NHSNPopulationSummaryReportTypeCodeactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.6007NHSNVascularAccessTypeCodeactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.6008NHSNSuspectedSourceTypeCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.6042NHSNVascularAccessSiteCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.6051NHSNClosureTechniqueCodeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.6074NHSNStaphAureusTestResultsactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7160NHSNStaphAureusSpecificTestactive2020-07
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7214NHSNSameDayOutcomeMeasureactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7215NHSNInfectionFirstReportedSourceactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7232NHSNRaceCategoryactive2020-06
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7233NHSNPreviousPatientLocationactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7237NHSNBloodCollectionLocationactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7238NHSNPreviousFacilityactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7239NHSNContraindicationTypeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7240NHSNCarbaTestMethodactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7241NHSNCarbaDetectTypeactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7242NHSNCdiffTestMethodactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7338NHSNStartOrContinuationactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.7353NHSNSummaryBloodProductUsageactive2020-08
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.836Raceactive2012-10
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.837Ethnicityactive2012-10
us.nlm.vsacR4ValueSet/2.16.840.1.114222.4.11.877Detailed Ethnicityactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.113883.3.67.1.101.3.2444Major Depression Including Remissionactive2021-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1222.140Ferritinactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.12.1005Rheumatoid Arthritisactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.11.1080Rheumatoid Arthritisactive2021-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.113.11.1081Rheumatoid Arthritisactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1222.1428Myalgiaactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1222.1439Vomitingactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1222.1525Cognitive disorder Diagnosis ICD10active2024-06
hl7.fhir.us.ccdaR4ValueSet/2.16.840.1.113883.11.20.4.1DischargeSummaryDocumentTypeCodetrial-usecgp2025-07
hl7.fhir.us.ccdaR4ValueSet/2.16.840.1.113883.1.11.20.22HPDocumentTypetrial-usecgp2025-07
hl7.fhir.us.ccdaR4ValueSet/2.16.840.1.113762.1.4.1099.10Care Plan Document Typetrial-usecgp2025-07
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.1139S4G Hyperlipidemiaactive2022-08
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.1291S4G Cardiomyopathyactive2022-08